AM-928

· AcadeMab Biomedical Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AM-928, covering 2025-06-18 to 2025-06-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety of AM-928 Infusion in Advanced Solid Tumors [Phase 1]